awmsg logo



pegvaliase (Palynziq®)


Reference No. 3097

Publication date:
18/09/2019


Appraisal information

pegvaliase (Palynziq®) 2.5 mg solution for injection
pegvaliase (Palynziq®) 10 mg solution for injection
pegvaliase (Palynziq®) 20 mg solution for injection


Company: BioMarin International Ltd
BNF category: Nutrition and blood
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 16/09/2019

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, pegvaliase (Palynziq®) cannot be endorsed for use within NHS Wales for the treatment of patients with phenylketonuria (PKU) aged 16 years and older who have inadequate blood phenylalanine control (blood phenylalanine levels greater than 600 micromol/l) despite prior management with available treatment options.
Statement of Advice (SOA)
Download